Jayson Dallas

Jayson Dallas

Director/Board Member chez GALECTO, INC.

Fortune : - $ au 31/03/2024

56 ans
Health Technology
Consumer Services

Profil

Jayson Donald Alexander Dallas is currently the Chief Executive Officer at Rivus Pharmaceuticals, Inc. since 2023 and an Independent Director at Galecto, Inc. since 2020.
Previously, he served as the President, Chief Executive Officer & Director at Aimmune Therapeutics, Inc. from 2018 to 2020, an Independent Director at Arena Pharmaceuticals, Inc. from 2017 to 2022, the Head-Global Product Strategy Inflammation at Genentech, Inc. from 2010 to 2012, the Chief Commercial Officer & Senior Vice President at Ultragenyx Pharmaceutical, Inc. from 2016 to 2018, and the General Manager at Roche Holding (UK) Ltd.
from 2012 to 2015.
Dr. Dallas obtained his undergraduate degree from Knox College, a doctorate from the University of the Witwatersrand, and an MBA from Ashridge Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/06/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Jayson Dallas

SociétésPosteDébut
GALECTO, INC. Director/Board Member 19/11/2020
Chief Executive Officer 29/06/2023
Tous les postes actifs de Jayson Dallas

Anciens postes connus de Jayson Dallas

SociétésPosteFin
ARENA PHARMACEUTICALS Director/Board Member 11/03/2022
AIMMUNE THERAPEUTICS, INC. Chief Executive Officer 01/10/2020
ULTRAGENYX PHARMACEUTICAL INC. Corporate Officer/Principal 18/06/2018
Corporate Officer/Principal 01/07/2015
Corporate Officer/Principal 01/12/2012
Voir l'expérience en détail de Jayson Dallas

Formation de Jayson Dallas

Knox College Undergraduate Degree
University of the Witwatersrand Doctorate Degree
Ashridge Business School Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jayson Dallas

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ULTRAGENYX PHARMACEUTICAL INC.

Health Technology

GALECTO, INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jayson Dallas